Clinical Trial Update: PVSRIPO for Recurrent Glioblastoma (GBM) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for PVSRIPO in recurrent glioblastoma (GBM) completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma
• Malignant Glioma

Drugs mentioned

• PVSRIPO

Snippet

Sponsor: Istari Oncology, Inc. | Conditions: GBM, Glioblastoma | Phase 1 | Status: COMPLETED | Results posted: 2018-09-28